Inspection and Receiving of CGMP Process Gases

What this document is for

In a pharmaceutical manufacturing environment, the strategic necessity of gas integrity cannot be overstated. Process gases often serve as critical reagents or provide the inert environment necessary for product stability; consequently, they are frequently in direct contact with the product or product-contact surfaces.

The full text is not reproduced here. Preview any document free on the catalog page, then buy the complete catalog in your language.

Ships as

Grounded in

FDA 21 CFR 210/211 and Part 11, EU GMP (EudraLex Volume 4, including Annex 1 and Annex 11), ICH Q7–Q12, and WHO GMP. Supplied in 13 languages.

Other Inspection & Audit documents

• Deviation Management and Investigation
• Acceptance Quality Limit (AQL) Inspection for Parenteral Labeling and Packaging
• Customer Complaint Management
• Customer Complaint Record
• Global Supplier Quality Audit Management
• Handling and Investigation of Microbiological Data Deviations
• Incoming Inspection of Labeling and Packaging Materials
• Internal Quality Audit Program